Centre de Radiothérapie - Clinique Sainte Anne
- Address
- 184 Route de la Wantzenau, 67000 STRASBOURG, Alsace, France
Centre de Radiothérapie - Clinique Sainte Anne
The Centre de Radiothérapie at Clinique Sainte Anne is a specialized oncology research center with extensive expertise in combined modality cancer therapy, particularly integrating radiotherapy with systemic treatments. The center demonstrates a strong commitment to advancing cancer care through participation in innovative phase II and III clinical trials across multiple solid tumor types.
- Gastrointestinal oncology including colorectal cancer, anal squamous cell carcinoma, and oeso-gastric adenocarcinoma with novel chemotherapy combinations and targeted therapies
- Genitourinary malignancies encompassing metastatic castration-resistant prostate cancer and urothelial carcinoma treatment optimization
- Head and neck cancer chemoradiotherapy with immunotherapy integration and precision radiotherapy approaches
The center's research portfolio reflects expertise in chemoradiotherapy protocols, particularly evaluating optimal sequencing of induction chemotherapy, concurrent chemoradiation, and maintenance immunotherapy. Their participation in landmark trials investigating circulating tumor DNA-guided therapy, novel targeted agents including KRAS G12C inhibitors, and immunotherapy combinations demonstrates commitment to personalized medicine approaches. The center also contributes to studies in hematologic malignancies such as polycythemia vera, showcasing diverse therapeutic expertise beyond solid tumors.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 of 8 therapeutic areas and 15 of 91 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 88 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 14 by active trials.
- 1Unicancer4active
lock +13 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +6 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre de Radiothérapie - Clinique Sainte Anne
lock Showing 1 of 42 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2, Open-label, Multi-cohort Study to Assess the Efficacy and Safety of ASP5541 in Participants with Advanced Prostate Cancer | Astellas Pharma Global Development Inc. | Phase II | Recruiting | Dec 2025 | — |
IMP list
lock Showing 1 of 91 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Fluorouracil | 7 | Unknown | 2014-12-23 | 2026-05-07 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.